Company Encyclopedia
View More
name
Bausch Health
BHC.US
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products.
4.599 T
BHC.USMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking60/184
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-41.63%E
    • Profit Margin3.61%C
    • Gross Margin72.03%A
  • Growth ScoreB
    • Revenue YoY5.86%C
    • Net Profit YoY303.37%A
    • Total Assets YoY1.07%C
    • Net Assets YoY247.11%A
  • Cash ScoreB
    • Cash Flow Margin2770.44%A
    • OCF YoY5.86%C
  • Operating ScoreC
    • Turnover0.38C
  • Debt ScoreE
    • Gearing Ratio98.67%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bausch Health Announces Early Exchange Offer Results for Exchange Offers

    Bausch Health announced early results of its exchange offer for senior secured notes. As of December 8, 2025, $2.69 billion of existing notes were tendered, exceeding the $1.6 billion maximum for new 10% notes due 2032. Withdrawal rights expired, and the offer ends December 23, 2025. Eligible holders include qualified institutional buyers and non-U.S. persons.

    MorningStar·
    US
    BHC
    -1.28%
    MorningStar·
    US
    BHC
    -1.28%

    Bausch Health Announces Early Exchange Offer Results for Exchange Offers | BHC Stock News

    Bausch Health announced early results of its exchange offers for senior secured notes due 2028. As of December 8, 2025, $2.69 billion of notes were tendered, exceeding the $1.6 billion maximum for new 10% notes due 2032. Withdrawal rights expired, and offers will close on December 23, 2025. New notes are offered to qualified institutional buyers and non-U.S. persons, subject to conditions.

    StockTitan·
    US
    BHC
    -1.28%
    StockTitan·
    US
    BHC
    -1.28%

    Why Bausch Health (BHC) Is Up 9.1% After John Paulson Deepens His Stake – And What's Next

    Investor John Paulson increased his stake in Bausch Health Companies by 2.5 million shares, boosting his total to 73.3 million shares. This move has drawn attention to Bausch Health's efforts in balance-sheet repair and its late-stage pipeline in gastroenterology and hepatology. The company's refinancing package and potential Medicare pricing threats are key factors for investors. Bausch Health's projected revenue is $10.1 billion by 2028, with varying fair value estimates from the Simply Wall St Community.

    Simplywall·
    US
    BHC
    -1.28%
    Simplywall·
    US
    BHC
    -1.28%

    TSX Swoons to End Week

    The TSX fell 166.16 points due to weakness in gold and health-care stocks. Laurentian Bank's Q4 profits missed estimates, and Fairfax Financial sold shares in Orla Mining. TD shares rose, while Bausch Health and Wesdome Gold declined. Statistics Canada reported 54,000 new jobs in November, with unemployment at 6.5%. The Bank of Canada is expected to hold interest rates. On Wall Street, the S&P 500 rose, driven by inflation data. Netflix shares fluctuated after a deal with Warner Bros. Discovery. The PCE index was 2.8%, and the 10-year Treasury yield increased.

    Baystreet·
    US
    BHC
    -1.28%
    US
    NFLX
    +1.17%
    Baystreet·
    US
    BHC
    -1.28%
    US
    NFLX
    +1.17%

    TSX Down 140 Points at Midday With Info Tech The Worst Performer

    The Toronto Stock Exchange is down 140 points at midday, with info tech as the worst performer, down 2.5%. Healthcare is the biggest gainer, up 2.8%, driven by Bausch Health's acquisition of Shibo Group. RBC Capital Markets updated its Canadian FEW Portfolio for 2026, noting a 5.4% return over three months. Edward Jones reports TSX is on track for its strongest year since 2009.

    fidelity·
    US
    BHC
    -1.28%
    fidelity·
    US
    BHC
    -1.28%
    © 2025 Longbridge｜Disclaimer